Pharmacological Control of Calcium and Potassium Homeostasis: Biological, Therapeutical, and Clinical Aspects by T. GodfraindPharmacological Control of Calcium and Potassium Homeostasis: Biological, Therapeutical, and Clinical Aspects by T. Godfraind

Pharmacological Control of Calcium and Potassium Homeostasis: Biological, Therapeutical, and…

EditorT. Godfraind, G. Mancia, M.P. Abbracchio

Paperback | October 11, 2012

Pricing and Purchase Info

$282.80 online 
$297.95 list price save 5%
Earn 1,414 plum® points

Prices and offers may vary in store

Quantity:

In stock online

Ships free on orders over $25

Not available in stores

about

This up to date treatment of calcium and potassium channel pharmacology first presents both molecular and preclinical pharmacology data, followed by contributions on the clinical application of the drugs that modulate calcium and potassium channels. Cardiovascular data prevail, but other chapters also discuss possible roles and application to the nervous system. Further, some contributions deal with future prospects in the area. Audience: Researchers, both pharmacological and medical, working in cardiovascular medicine with strong interests in the treatment of myocardial infarction and hypertension.
Title:Pharmacological Control of Calcium and Potassium Homeostasis: Biological, Therapeutical, and…Format:PaperbackDimensions:293 pages, 9.45 × 6.3 × 0 inPublished:October 11, 2012Publisher:Springer NetherlandsLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:9401040567

ISBN - 13:9789401040563

Reviews

Table of Contents

Preface. I: Molecular biology and pharmacology of cell calcium and potassium. II: Calcium and potassium regulation in cardiovascular pathophysiology. III: Calcium antagonists in cardiovascular therapy and organ protection. IV: Calcium and potassium manipulation in the prevention and reversal of structural changes in hypertension. V: Beyond blood pressure reduction: tissue protection by calcium antagonism can be enhanced by ACE inhibitors. VI: Multicenter Israpidine diuretic atherosclerosis study (MIDAS): results and lessons learned. VII: Calcium and potassium homeostasis in cerebral ischemia and neurodegenerative disorders. VIII: Molecular and clinical aspects of current and novel uses of potassium channel openers. Index.